World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—
Cleo Diagnostics Ltd in brief
Cleo Diagnostics Ltd is a listed company in the Healthcare sector, based in Australia. Its shares trade under the symbol COV.AX (ASX).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Market cap history
Not enough history yet.
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Cleo Diagnostics Ltd🇦🇺 | — | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
How current the figures are
- Profile updated:
- Nov 5, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Cleo Diagnostics Ltd? Verify and update this profile — free
Show Cleo Diagnostics Ltd's ranking on your website Get the badge
The badge updates itself as the ranking changes.